Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Assets Average (2016 - 2025)

Historic Assets Average for Standard Biotools (LAB) over the last 15 years, with Q3 2025 value amounting to $548.3 million.

  • Standard Biotools' Assets Average fell 2112.32% to $548.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $548.3 million, marking a year-over-year decrease of 2112.32%. This contributed to the annual value of $467.7 million for FY2024, which is 3112.45% up from last year.
  • Latest data reveals that Standard Biotools reported Assets Average of $548.3 million as of Q3 2025, which was down 2112.32% from $568.3 million recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Assets Average registered a high of $743.2 million during Q2 2024, and its lowest value of $273.6 million during Q1 2022.
  • In the last 5 years, Standard Biotools' Assets Average had a median value of $381.0 million in 2023 and averaged $442.6 million.
  • As far as peak fluctuations go, Standard Biotools' Assets Average skyrocketed by 10432.13% in 2024, and later crashed by 2353.59% in 2025.
  • Standard Biotools' Assets Average (Quarter) stood at $278.7 million in 2021, then skyrocketed by 44.46% to $402.6 million in 2022, then decreased by 17.74% to $331.2 million in 2023, then surged by 95.35% to $646.9 million in 2024, then fell by 15.25% to $548.3 million in 2025.
  • Its Assets Average stands at $548.3 million for Q3 2025, versus $568.3 million for Q2 2025 and $596.0 million for Q1 2025.